<DOC>
	<DOCNO>NCT00106938</DOCNO>
	<brief_summary>The study conduct demonstrate non-inferiority carotid artery stenting ( CAS ) use Emboshield® Embolic Protection System Xact® Carotid Stent System carotid endarterectomy ( CEA ) treatment asymptomatic extracranial carotid atherosclerotic disease .</brief_summary>
	<brief_title>Carotid Angioplasty Stenting Versus Endarterectomy Asymptomatic Subjects Who Are Standard Risk Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease ( ACT I )</brief_title>
	<detailed_description>Randomization ACT 1 employ 3:1 ratio CAS versus CEA . A lead-in phase 400 carotid stent subject provide investigator experience study device prior pivotal enrollment .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>Severe carotid artery disease Patients symptom related carotid artery disease last 180 day Patients able undergo either interventional stenting surgical procedure Patients symptoms last 180 day Patients high risk surgery Patients certain condition might confound result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Carotid stenting</keyword>
	<keyword>Carotid endarterectomy</keyword>
	<keyword>Carotid artery disease severe narrowing artery</keyword>
	<keyword>Stroke prevention</keyword>
</DOC>